+91-9896593699
Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.
Median survival in metastatic carcinoma breast is 2 years.5 year survival is close to 25% (i.e. one out of 4 patients of metastatic breast cancer will be alive at 5 years).New Class of drugs - CDK4 & 6 inhibitor (Palbociclib, Ribociclib) have bee
View DetailsIn india 14-20 percent lung cancer patients are wrongly diagnosed and treated as pulmonary tuberculosis leading to delay in treatment. Burden of ALK positivivity in unselected adenocarcinoma lung is low.(4 percent)But in selected group of never o
View Details